Feed Insights Top Reports Pricing

⌘K

08:06:34·1114d

SECFilingvia Quantisnow

SEC Form 10-K filed by Doximity Inc.

ByQuantisnow·Wall Street's wire, on your screen.

DOCS· Doximity Inc.

Technology

Plus alert sent

Quantisnow Plus members were alerted at 08:06:35 ET - 1.8s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment DOCS files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DOCS (Doximity Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Interim PAO Sitaram Siddharth sold $49,882 worth of shares (2,444 units at $20.41) as part of a pre-agreed trading plan and converted options into 5,000 shares, increasing direct ownership by 3% to 90,706 units (SEC Form 4) to satisfy withholding obligation
Doximity to Present at the William Blair 46th Annual Growth Stock Conference
Interim PFO and PAO Sitaram Siddharth covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 1% to 88,150 units (SEC Form 4) (tax liability)
Chief Executive Officer Tangney Jeffrey was granted 322,614 shares and covered exercise/tax liability with 14,964 shares, increasing direct ownership by 14% to 2,540,460 units (SEC Form 4) to satisfy tax liability
SEC Form S-8 filed by Doximity Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022